首页 | 本学科首页   官方微博 | 高级检索  
     


Advanced hilar cholangiocarcinoma: An aggressive surgical approach for the treatment of advanced hilar cholangiocarcinoma: Perioperative management,extended procedures,and multidisciplinary approaches
Affiliation:1. Division of Transplant Surgery, Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin;2. The Transplant Center, Froedtert and The Medical College of Wisconsin, Milwaukee, Wisconsin;3. Division of Hematology and Oncology, Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin;4. Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin;1. Department of Surgery, Cancer Center Amsterdam, Amsterdam UMC, University of Amsterdam, the Netherlands;2. Clinical Research Unit, Amsterdam UMC, University of Amsterdam, the Netherlands;1. Division of Transplantation Surgery, Department of Surgery, University of Nebraska Medical Center, 983285 Nebraska Medical Center, Omaha, NE 68198, USA;2. Section of Abdominal Organ Transplant, Department of Surgery, Washington University School of Medicine, Washington University, 660 South Euclid Avenue, Campus Box 8109, St Louis, MO 63110, USA;1. Department of Surgery, Erasmus MC University Medical Center, Rotterdam, The Netherlands;2. Department of Surgery, Academic Medical Center, Amsterdam, The Netherlands;3. Department of Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands;4. Department of Medical Oncology, Academic Medical Center, Amsterdam, The Netherlands;5. Department of Radiology, Academic Medical Center, Amsterdam, The Netherlands
Abstract:Hilar cholangiocarcinoma is a highly intractable malignancy. One of the reasons for its intractability is that most patients with the disease are diagnosed with an advanced stage of the disease at their initial presentation. Surgical resection is the standard therapy for hilar cholangiocarcinoma, providing a chance for a cure, and an aggressive surgical approach substantially increases the number of resectable tumors that are initially regarded as unresectable tumors. The success and standardization of the aggressive approach is warranted by meticulous preoperative management that prevents fatal postoperative complications. Extended resection procedures, including hepatic trisectionectomy for Bismuth type IV tumors, hepatopancreaticoduodenectomy for tumors with extensive longitudinal tumor spreading, and combined vascular resection with reconstruction for tumors with the involvement of hepatic vascular structures, have been challenged to expand the surgical indication. Due to acceptable surgical/survival outcomes, the three extended procedures are currently regarded as extended but standard options in specialized hepatobiliary centers. Although it remains a controversial multidisciplinary approach, the combination of these extended procedures with an adjuvant/neoadjuvant treatment is a promising approach for further improving the resectability of tumors and the survival of patients.
Keywords:Perihilar cholangiocarcinoma  Vascular reconstruction  Hepatopancreaticoduodenectomy  HPD"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0030"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  hepatectomy with pancreaticoduodenectomy  PVR"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0040"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  combined resection with reconstruction of the portal vein  HAR"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0050"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  combined resection with reconstruction of the hepatic artery  HAPVR"  },{"  #name"  :"  keyword"  ,"  $"  :{"  id"  :"  kwrd0060"  },"  $$"  :[{"  #name"  :"  text"  ,"  _"  :"  combined simultaneous resection of the hepatic artery and portal vein
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号